Clinical Trial Update: Pharmacogenomics in Autism Treatment [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical trials investigating pharmacogenomics strategies for autism treatment have completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: University of California, San Francisco | Conditions: Autism | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-07-24